Clinical trial
ADVATE Post Authorization Safety Surveillance
NCT00214734 · Baxalta now part of Shire, Industry · Completed
Key facts
| NCT number | NCT00214734 |
|---|---|
| Title | ADVATE Post Authorization Safety Surveillance |
| Official title | Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study |
| Lead sponsor | Baxalta now part of Shire, Industry |
| Collaborators | Baxter BioScience Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Hemophilia A |
| Intervention type | Drug |
| Interventions | rAHF-PFM |
| Enrollment | 108 |
| Start date | Oct 14, 2004 |
| Completion | Mar 2, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Mar 17, 2021 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: